To further support these critical roles of CD4+ T cells in eCCA, Tran et al. demonstrated the regression of metastatic cholangiocarcinoma following the infusion of CD4+ T cells specific to a neo-antigen (mutated ERBB2IP) [42]. This evidence concerns the gene CD4 and cholangiocarcinoma.